Vitrifi cation is an excellent tool in the IVF laboratory, enabling options and offering fl exibility in assisted reproduction. The technology of cryopreservation has been underway since the early 20 th century. The advent of vitrifi cation has advanced the expectations in routine clinical practice in the IVF laboratory presenting impressive results both in post-thaw survival, and in clinical pregnancy rates, as well as signifi cantly enhancing clinical results on preimplantation genetic diagnosis (PGD). Contradicting opinions have been published recently on the limitations and potential that vitrifi cation has in the laboratory, as well as on the optimal approach to employ vitrifi cation in IVF. This review aims to present a comprehensive analysis of the practical aspects of vitrifi cation including concerns and options regarding its use on oocytes and embryos while comparing it with the traditional "slow-freezing" cryopreservation technique.
INTRODUCTION
In 1937, Luyet wrote that "crystallization is incompatible with any living organism/system, and should be avoided whenever possible". 1 There are two major aspects of physical stress in which cells are exposed during cryopreservation: fi rstly, the direct impact of cooling (cold shock injury) which is associated with changes in membrane permeability and cytoskeletal structure 2 , and secondly, the destruction of cell structure and function that takes place with the creation of ice crystals. The solution to these two major issues was found by the use of cryoprotectants and the application of suitable cooling and warming rates. 3 The development of In Vitro Fertilization (IVF) in 1978 gave a further boost to cryobiology and soon the first pregnancies from cryopreserved gametes and embryos were published. 4 The problems of cryopreservation with the level of survival were quickly identifi ed and satisfactory solutions are being sought and tested to date, aiming to ultimately eliminate the detrimental implications of cryopreservation. In other words, the objective has been and still remains "not to freeze the embryo/ gamete, but to "freeze time" for that subject."
THE NECESSITY FOR A RELIABLE CRYOPRESER-VATION TECHNIQUE IN THE IVF LABORATORY
The possibility of cryopreserving embryos and gametes with high survival rates offers tremendous fl exibility revolutionizing the entire range of fertility treatments.
The production of multiple embryos in IVF, coupled with the fact that the latest trends in the fi eld favour single embryo transfer at the blastocyst stage, results in surplus embryos. If cryopreserved, these surplus embryos can be used in a future cycle signifi cantly improving cumulative implantation and pregnancy rates. 5 The excellent prognosis of vitrifi cation on embryo survival and maintenance of implantation potential already contributes to opting for a single embryo transfer signifi cantly thereby reducing the chances of multiple births in the fi eld of IVF. Such multiple gestations have raised valid concerns within the clinical scientifi c community. 5 Moreover, in cases where it is deemed necessary to cancel fertilization due to diffi culties in collecting semen or to postpone the embryo transfer due to a developing ovarian hyperstimulation syndrome 6 , the option of vitrifying oocytes/embryos can act in a facilitating fashion to such a decision 7 .
Finally, the contribution of vitrifi cation to the fi eld of "fertility preservation" and of Preimplantation Genetic Diagnosis/Screening (PGD/PGS) is further analyzed below.
SLOW-FREEZING: THE TRADITIONAL METHOD OF CRYOPRESERVATION
Initially, the cryopreservation of gametes and embryos was applied according to slow-freezing protocols. According to these protocols the cells are suspended in a solution containing 10-15% of a cryoprotectant and then are subjected to cooling with a rate of approximately 0.3-1 o C per minute. 8 The cells dehydrate during freezing thus little or no intracellular ice is formatted making possible the survival of cells after cooling and subsequent thawing. Signifi cantly, the success of the method was based on the use of suitable cryoprotectants (CPAs), which are small water-soluble molecules that serve as antifreeze colligative agents by breaking hydrogen bonds in water molecules. In this way they lower the freezing point by replacing osmotically the intracytoplasmic water molecules. According to their permeability they are classifi ed in permeable (dimethyl sulfoxide (Me2SO-DMSO), ethylene glycol (EG), glycerol, propanediol) and impermeable (sucrose, trehalose, raffi nose, fi coll, macromolecules). Their nature is toxic and therefore a fi ne balance is required with respect to the dehydration speed, which is directly proportional to their concentration. Excessive dehydration will increase the intracellular concentration of cryoprotectants to dangerously high toxic levels. 9 The introduction of slow-freezing in the everyday clinical practice was followed by massive cryopreservation of surplus embryos and establishment of freeze-thaw cycles as a reliable option for couples participating in IVF programs. However, the results from cryopreservation of oocytes were disappointing. 10 
VITRIFICATION METHOD
Vitrifi cation is the second major method of cryopreservation that has been introduced into clinical practice recently. Etymologically, vitrifi cation derives from the Latin word «vitreum» which means "glass." It involves the conversion of a liquid substance into a glass-like, non-crystalline structure by rapid freezing. Vitrifi cation achieves minimization of crystal formation within the cytoplasm of cells, which is the main cause of injury challenging its viability. This success is based on two basic elements: Firstly, before cooling, gametes/embryos are placed in the appropriate cryoprotectant which causes dehydration 12 Hereby we analyze the options and the concerns that arise in this respect.
Comparing the traditional technique of cryopreservation to vitrifi cation, there are some basic differences in the protocols that involve the intracellular cryoprotectants concentration in vitrifi cation which is up to four times higher. Cooling rates in vitrifi cation reach the 25,000°C/min compared with the gradual freezing rate that characterizes the traditional cryopreservation protocols at 0.3-1°C/ min. Different vitrifi cation protocols have been developed all characterized by high survival rates after thawing. [13] [14] [15] [16] [17] Regarding the cryoprotectants used in vitrifi cation protocols, the combination EG-ME2SO is the most commonly used and it achieves excellent results. However, the toxicity of ME2SO has been often questioned and scrutinized and while some laboratories opt for ME2SO free protocols, several important studies have demonstrated that the use of ME2SO can lead to reduced chemical damage protecting the membrane integrity and stabilizing the cellular osmolarity. [18] [19] [20] The basic steps in vitrifi cation and warming protocols are: a) Exposure of embryos/gametes to progressively higher concentrations of cryoprotectants aiming towards dehydration, b) loading of embryos/gametes on a carrier of choice in the smallest volume required, c) rapid freezing-vitrifying at -196°C, d) storage, e) warming by exposure to gradually lower concentration of cryoprotectants aiming towards rehydration and "washing" in order to remove cryoprotectant material and restore the physiological environment. In an effort to improve and ensure a successful vitrifi cation we employ the following: a) loading of embryos/gametes onto the carrier of choice employing a minimal volume (0.5 -2 μl) allowing in turn a maximum speed of freezing, b) combining different cryoprotectants, which allows the use of lower concentrations of cryoprotectants thus aiming to reduce toxic and osmotic damage, and c) achieving extremely high cooling rates and even higher warming rates. 21, 22 Studies show that warming rates may be more important than those of cooling as achieving warming rates of 42,000°C/min ensures a fast passage from the harmful temperature zone which is responsible for the chilling injury and affects the meiotic spindle and cytoplasmic lipid droplets. 23 
VITRIFICATION VERSUS SLOW-FREEZING
The central points of comparison are as follows: the traditional method of slow freezing employs freezing equipment and a program that has a duration of 2-3 hours with very high consumption of liquid nitrogen, while vitrifi cation takes place in just 15 minutes without requiring specifi c equipment and with minimum consumption of liquid nitrogen.
Intracytoplasmic crystal formation and mechanical damage have been observed in slow-freezing 24 , while crystal formation can be totally avoided with vitrifi cation.
Unlike slow-freezing, vitrifi cation requires higher concentration of cryoprotectant agents for maximum and safe dehydration of embryos/gametes, a fact which in turn increases the toxicity, chemical and osmotic damage.
The majority of studies support vitrifi cation over slow-freezing as the metabolic arrest is not permanent but reversible, which is proven by a study on the consumption levels of pyruvate. 21 Moreover, other studies have shown that vitrifi cation offers the unique opportunity to submit a vitrifi ed and warmed embryo to subsequent vitrifi cation without affecting its viability. 25, 26 In summary, this comparison proves vitrifi cation to be an option that is clearly cheaper, faster and safer as to effects on metabolism and mechanical damage, and clinical results are impressive. Essentially, the only points where traditional slow cryopreservation outweighs the method of vitrifi cation concern the risk of contamination and toxicity. There are studies which suggest that simple modifi cations to slow cryopreservation protocols can bring signifi cant results and better survival rates. 27 Additional comparative studies are required to improve the conditions of vitrifi cation and showcase which combination, concentration of cryoprotectants, and carrier option ensure best results. It has been demonstrated by three different meta-analysis studies that the vitrifi cation technique, when applied to both zygotes and embryos, exerts the least effect on their physiology while it ensures higher survival and pregnancy rates. [28] [29] [30] In order to achieve extremely high speeds and avoid formation of crystals various devices/carriers have been developed to expose the loaded oocytes/ embryos directly to liquid nitrogen (LN 2 ) employing the mini drop size MDS technique 31 giving rise to what is known as the "open system". Despite the advantages of employing the open system carriers, the embryos/gametes are at risk regarding sterilization issues, i.e. contamination, which raises concerns about their safety, especially when they are transported. 32 Numerous germs, bacteria, and viral agents can survive at low temperatures including LN (-196°C) 33 , and act as transmissible pathogens transecting the cryopreserved embryos/ gametes. Sources of contamination may be the embryos/gametes themselves, the culture media, the equipment and laboratory environment, the liquid nitrogen, and the containers for transport and storage. 32 To avoid the above risk one could opt for carriers that are tightly closed and sealed known as the "closed system", ensuring security against the risk of contamination, but "sacrifi cing" one pivotal idea of the success of vitrifi cation, as cooling rates are signifi cantly reduced from > 20,000°C/min to 1,500-5,000°C/min because of the reduced heat conduction through the walls of the closed carrier. 22 The decision of every IVF laboratory as regards choosing the open or closed system depends largely on the relevant legislation for each country such as the Code of Practice regulations, as well as the Tissue Directive Guidelines. It is worth noting that there is no law that prohibits the use of the open system due to contamination risks, and recent studies show that the use of "open" compared with the "closed" system ensures better results. 34 Pomeroy 35 has shown that pathogens do not adhere to the zona pellucida which serves as a physical barrier. Moreover, using PCR, Cobo 6 analyzed samples of residual material from liquid nitrogen storage for 63 seropositive patients, and found no viral contamination. Having thoroughly demonstrated that the open system ensures better survival rates, the question then arises: How can we modify the open system to avoid the possibility of contamination? Firstly, we need to ensure maximum degree of disinfection of containers and equipment -an essential feature of any well-functioning IVF laboratory. Secondly, during vitrifi cation we could employ sterilized LN 2 by sterile fi ltration LN 6 , or by UV irradiation 36 , and sterile storage of individual containers. Regarding the issue of storage, Cobo proposed storage in vapor, while in vitro laboratories worldwide develop their own patents on a closed system for storage. 37 
BLASTOCYST VITRIFICATION
The fi rst pregnancy from a vitrifi ed blastocyst was reported by Yokota et al. 38 It has been thoroughly documented that blastocyst embryo transfer ensures optimal embryo selection with respect to its implantation potential and hence higher rates of clinical pregnancy. This is further supported by the fact that the embryo at the blastocyst stage has successfully achieved activation of the embryonic genome and is in sync with the intrauterine environment 8 , while exhibiting greater resistance to toxicity and metabolic stress, and better survival rates. When a group of embryos is subjected to a blastocyst culture, there are fewer embryos available for cryopreservation therefore a reliable method of cryopreservation is of paramount importance. It is equally important to employ strict criteria for the use of blastocyst culture which should be more rigorous than those concerning vitrifi cation of cleavage stage embryos. The surface to volume ratio is lower in oocytes, zygotes and cleavage stage embryos than the surface to volume ratio of the blastocyst 22, 39 , therefore blastocysts exhibit a higher capacity to dehydrate and replace water molecules with cryoprotectant molecules. The technique of assisted shrinkage/ artifi cial collapse of the blastocyst is performed by application of one laser shot 500 ms at the trophectoderm cell junction, or by employing microneedles to pierce zona pellucida and subsequently to microaspirate mechanically. In both cases the blastocoel cavity collapses in 2-3 minutes allowing blastocyst vitrifi cation following a ten-minute culture. This technique reduces the incidence of intracellular crystal formation due to total dehydration of the cavity of the blastocyst, thereby enhancing the accessibility of the cryoprotectant. Increased survival and pregnancy rates have been reported. 40 
OOCYTE VITRIFICATION
The technique of vitrifi cation opened a huge new chapter in the oocyte cryopreservation book. The fi rst birth following oocyte vitrifi cation occurred in 1999. 41 The survival rates following slow traditional cryopreservation present at rather disappointing levels 50-65%. 10 Analysis of human oocytes and comparison between vitrifi cation and cryopreservation led to major fi ndings, namely the slow freezing category presented with increased vacuolation, intracytoplasmic organelle displacement and increased 42 Cao 43 showed a striking difference in survival rates, fertilization, cleavage, development of good quality embryos and blastocysts, between oocytes which were slow frozen and those that were vitrifi ed. In fact, the percentage of blastocyst development appears to be almost three times higher than that in the traditional cryopreserved group.
The possibility of oocyte vitrifi cation following ovarian stimulation coupled with the high survival rates that characterize the technique has opened the possibility for a sophisticated approach to infertility issues that involve medical, legal, ethical, and even social issues as the most effective method of cryopreservation. 37, 44, 45 More specifi cally, women with a malignant disease who have to undergo chemo/radio-therapy and/or oophorectomy, can opt for oocyte vitrifi cation prior to that, thereby preserving their genetic material. 46 Vitrifi cation offers options for women looking to preserve their oocytes because of premature ovarian failure. In countries where legislation on IVF practice prohibits cryopreservation of zygotes and embryos egg vitrifi cation offers the solution. 13 Gidoni reported the case of a mother vitrifying her oocytes, in order to ensure that her daughter affected by Turner's syndrome can procreate. 47 In cases of women of childbearing age for reasons which are not medical but "social" -a phenomenon which is becoming increasingly common in the Western world -the vitrifi cation technique offers more options towards maintaining their "fertility". 44, 45 A prospective study by Rienzi 48 demonstrated that vitrifi cation followed by an intracytoplasmic sperm injection gives as good results in terms of fertilization rates and fetal development as the fertilization of fresh non cryopreserved oocytes of the same cycle. Fertilization and cleavage rates as well as embryonic development appear to present with equal numbers in both fresh and vitrifi ed oocytes. 44 This fact paved the way for the development of vitrifi ed oocytes banks 49 , offering widespread availability, reducing the waiting list, and ensuring safety. Obstetric and perinatal studies in neonates originating from vitrifi ed oocytes provide valid evidence that there is no correlation between oocyte vitrifi cation and increased risk of adverse obstetric and perinatal fi ndings. 50, 51 Specifi cally, ovum vitrifi cation does not appear to increase the risk of abnormal epigenetics or disorders of meiotic spindle formation or abnormal chromosomal segregation. 52 Clearly, the application of vitrifi cation on oocytes does exert a negative effect on oocyte physiology. Further studies are required to elucidate in depth the effect of vitrifi cation and warming on oocyte physiology and particularly on the following: the biology of aging, the membrane permeability, the hardening of zona pellucida, cytoplasmic and cytoskeletal damage, and depolymerization of the meiotic spindle. 53, 54 The mechanisms of injury concern the following: a) mechanical damage due to crystal formation, b) osmotic and chemical damage caused by toxicity with respect to the type, concentration and time of exposure to cryoprotectants, c) chilling shock which causes changes affecting the liquidity and therefore the integrity of the membrane. However, this has been shown to be reversible 55 , in the same way as the disruption of meiotic spindle. More specifi cally, studies have shown that the depolymerization of beta-tubulin because of temperature changes, to which the spindle is extremely susceptible, is a completely reversible process whereas repolymerization takes place successfully following two hours of incubation, forming morphologically normal metaphases with properly aligned chromatin. 56 The repolymerization of the meiotic spindle following vitrifi cation is faster than in the slow cryopreservation, and Chen and Yang 57 suggest that the incubation time to restore the meiotic spindle is two hours following warming of vitrifi ed oocytes, and three hours for slow-frozen oocytes. Regarding the use of cryoprotectants, contradicting results have been published about the advantages and disadvantages of employing certain cryoprotectants and particularly ME2SO which has been suggested to be involved in microfi lament organization, and also in causing chromosomal abnormalities. 58 
VITRIFICATION AND PGD/PGS
PGD is the diagnosis of a genetic condition or a chromosomal abnormality on IVF embryos, enabling the transfer of unaffected embryos, hence avoiding a genetically or chromosomally imbalanced pregnancy. 61 Programs of PGD/PGS are subject to constant development. Combining this diagnostic tool with the technique of vitrifi cation has improved considerably clinical outcomes. 62 The main issues in the application of PGD/PGS are: a) the time available for diagnosis between the biopsy day and 166 63 Subsequent developments in the fi eld of molecular and cytogenetic approaches to the chromosomal analysis of embryos lead to comparative genomic hybridization (CGH) which ultimately gave rise to DNA microarrays allowing the screen of the entire chromosomal complement for deletions or duplications of genetic material in a single experiment. 64 The essential diagnostic time for application of this technique required the embryos to be cryopreserved following biopsy and transferred at a later date. The complex nature of PGD requires a reliable and robust cryopreservation program. Unfortunately, results from cleavage stage embryos that were biopsied and subsequently subjected to traditional cryopreservation were disappointing. 10 Furthermore, the scarce genetic material available for diagnosis (biopsy of 1-2 blastomeres on day 3 of development) soon led to the investigation of biopsy at the blastocyst stage 65 providing suffi cient material for diagnosis. Blastocyst biopsy however, required subsequent embryo cryopreservation, and embryo transfer taking place at a later date. 62 The fact that the vitrifi cation technique has been proven to ascertain excellent results regarding embryos at the blastocyst stage either following biopsy or not, has in fact revolutionized PGD and its practice. 66 Schoolcraft et al. 5 published survival rates following vitrifi cation of biopsied blastocysts of 100%. Such results allow for: a) more material available for a safe diagnosis (biopsy at the blastocyst stage ensures a group of cells from the trophectoderm), and b) more time to apply techniques that will provide information on the genetic profi le of the embryo as a whole, allowing selection of healthy embryos for embryo transfer.
CONCLUSIONS
Analyses of the dynamics of the meiotic spindle and fetal development show that the technique of vitrifi cation is less traumatic than the one of slow cryopreservation. 67 The quantifi cation of metabolic and proteomic dynamics of the oocyte proves that while slow cryopreservation has dramatic effects on physiology, vitrifi cation appears to exert a limited effect. 21 The benefi ts of employing the "open" versus the "closed" system far outweigh the negligible risk of contamination and the safety of the strategy is confi rmed by the obstetric and perinatal studies. 50, 51 The potential to build oocyte banks is now a reality offering excellent clinical results for all categories of patients. 44 Vitrifi cation at blastocyst stage is widely applied with great success and has contributed signifi cantly to the evolution of PGD/ PGS and the ability to screen the entire chromosomal complement in a single experiment, as well as in the reduction of multiple pregnancies by strengthening the strategy of blastocyst culture. 5 From a practical point of view, laboratory application of the technique of vitrifi cation ensures the coveted fl exibility required in the laboratory, as even slow developing embryos can be vitrifi ed individually. Vitrifi cation is a much more attractive option as a low cost clinical technique. The relationship between the carrier and protocol of choice, and the learning curve leading to the operator experience has been recognized for certain and further prospective randomized studies are required in order to compare different protocols and systems in the fi eld of cryopreservation. 68 Further research on the clinical application of vitrifi cation in the IVF laboratory should be encouraged especially in the fi elds of epigenetics, biotechnology, and toxicology in order to improve its application and shed more light into the grey areas that still require investigation.
